![]() |
Vibration Measurements on Dissolution Systems and Effects on Dissolution of Prednisone Tablets RSSaroj Vangani,Tawnya Flick,Germinia Tamayo, Rick Chiu, and Nina Cauchon Small Molecule Pharmaceutics, Amgen Inc,Thousand Oaks, CA In VitroñIn Vivo Correlation: Importance of Dissolution in IVIVCJ-M. Cardot, E. Beyssac, and M.Alric
Perturbation Study of Dissolution Apparatus VariablesóA Design of Experiment ApproachJoseph Eaton,Gang Deng,Walter W. Hauck,
William Brown, Ronald G. Manning,
and Samir Wahab
Evaluation of Glass Dissolution Vessel Dimensions and IrregularitiesMark R. Liddell,Gang Deng,Walter W. Hauck,
William E. Brown, Samir Z.Wahab, and Ronald G. Manning
Dissolution Highlights of the AAPS Annual MeetingVivian Gray1 and Saji Thomas2
Book Review: Injectable Dispersed Systems, Formulation, Processing and Performance Edited By Diane J. Burgess, Published by Taylor and Francis Group, Boca Raton FL, 2005 ISBN 0-8493-3699-6Anne-FranÁoise Aubry, Ph.D. Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ 08903 Question & Answer SectionMargareth Marques and William Brown
|
![]() |
Commentaries on Mechanical versus Chemical CalibrationContributing authors: Royal Hanson, Hanson Research; Saroj Vangani,Amgen; Alger Salt, GSK; John Burmicz, Pharma Test; Saji Thomas, Par Pharmaceutical, Jeff Seely,Distek; Johannes Kraemer, PHAST Laboratories, Jon Kretz,Watson Pharmaceuticals; and Bryan Crist,Varian The Effects of Buffer Molarity,Agitation Rate, and Mesh Size on Verapamil Release from Modified- Release Mini-Tablets Using USP Apparatus 3Sandile M. M. Khamanga and Roderick B.Walker
Application of USP Apparatus 7 to In Vitro Drug Release in Scopolamine Transdermal SystemsMarilyn X. Zhou,Duane Shoudt,Genaro Calderon, and Min Feng
Attempt to Design Continuous DissolutionñAbsorption System Using Everted Intestine Segment for In Vitro Absorption Studies of Slow Drug Release FormulationsVinita V. Kale, Rahul H. Kasliwal, and Jasmin G.Avari
Technical Note: Total Dissolved Gas Pressure (TDGP) Sensing in the LaboratoryBrian G.DíAoust
Question & Answer SectionMargareth Marques and William Brown
|
![]() |
Proposed Change to Acceptance Criteria for Dissolution Performance Verification Testing
Walter W. Hauck, Ronald G. Manning, Todd L. Cecil, William Brown, Roger L. Williams
Challenges with Dissolution Testing and Quality Assessment for Commercial Feverfew Products
Ping Jin1, Shadi Madieh2, and Larry L. Augsburger3
A Comparison of the Technical Quality of American and Japanese Ranitidine TabletsMakoto Otsuka1, Yuka Akizuki2, Kuniko Otsuka3, Shinichiro Yanagisawa4, Isao Kamae4, and
James A. Jorgenson5
Activities of the AAPS In Vitro Release and Dissolution Testing Focus GroupKailas Thakker1 and Vivian Gray2
Question & Answer SectionMargareth Marques and William Brown
|
![]() |
Simplified Biorelevant Media for Screening Dissolution Performance of Poorly Soluble Drugs
Thomas Zoeller and Sandra Klein
The Comparison of In Vitro Release Methods for the Evaluation of Oxytocin Release from PluronicÆ F127 Parenteral Formulations
F.A. Chaibva and R.B. Walker
Differences in In Vitro Dissolution Rates Using Single-Point and Multi-Point SamplingLimin Zhang1, Khanh Ha1, Brent Kleintop1, Shannon Phillips2, Barry Scheer1
A Comparative In Vitro Assay of Drug Release Performance of Pyridostigmine Bromide TabletsNoelia L. Gonzalez Vidal1,2, Patricia D. Zubata1, Laura D. Simionato1, Irma Ercolano1, and
Maria T. Pizzorno1,2
Technical Note: Miniaturized Intrinsic Dissolution Rate (Mini-IDR™) Measurement of Griseofulvin and CarbamazepineCynthia M. Berge1, Oksana Tsinman1, Dmytro Voloboy1, Dana Lipp1, Steven Stones2, and Alex Avdeef1
Meeting Report: AAPS/FDA Workshop on BE, BCS, and Beyond
Vivian Gray
Question & Answer SectionMargareth Marques and William Brown
|